SEP 10, 2026 · JOURNAL ARTICLE
Efficacy of a single dose of postoperative intravenous iron on erythropoietic recovery for Return to Intended Oncological Therapy in patients with head and neck cancer: A randomized controlled trial
Journal of Anaesthesiology Clinical Pharmacology
Single-centre RCT with clear methodology showing IV iron achieves greater absolute Hb rise than oral iron, but fails the primary endpoint of superior Hb at RIOT timepoint; result requires confirmation and clinical significance of the 0.55 g/dL difference is unclear.
Reported
Primary endpoint: Hb level at 4–6…10.91 ± 1.56 g/dL
Primary endpoint: Hb level at 4–6…10.94 ± 1.05 g/dL
P-value for intergroup Hb differe…0.907